Address:
Milenijna 43 lok. 2, 03-130 Warszawa
WWW:
About:
The company is pursuing a technology project to identify embolic material in blood vessels. According to the assumptions, the diagnostics is expected to enable the correct choice of treatment method treatment, which is expected to significantly reduce the mortality rate of patients with chronic atherosclerotic disease.